BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21415579)

  • 41. Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination.
    Winnock M; Bani-Sadr F; Pambrun E; Loko MA; Lascoux-Combe C; Garipuy D; Rosenthal E; Carrieri P; Dabis F; Salmon D
    Vaccine; 2011 Nov; 29(47):8656-60. PubMed ID: 21920402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Susceptibility to hepatitis A virus infection among chronic liver disease patients and healthy blood donors in Thailand.
    Pramoolsinsap C; Attamasirul K; Busagorn N; Maneerat Y; Nuchprayoon C; Tanprasert S; Srivatanakul P; Theamboonlers A; Hirsch P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):91-5. PubMed ID: 10695795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single-Dose Universal Hepatitis A Immunization in Argentina: Low Viral Circulation and High Persistence of Protective Antibodies Up to 4 Years.
    Vizzotti C; González J; Rearte A; Urueña A; Pérez Carrega M; Calli R; Gentile A; Uboldi A; Ramonet M; Cañero-Velasco M; Diosque M
    J Pediatric Infect Dis Soc; 2015 Dec; 4(4):e62-7. PubMed ID: 26582885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changing epidemiology of hepatitis A infection in Izmir, Turkey.
    Kurugol Z; Aslan A; Turkoglu E; Koturoglu G
    Vaccine; 2011 Aug; 29(37):6259-61. PubMed ID: 21763745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
    Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
    J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis A Seroprevalence Among Patients with Chronic Hepatitis B Infection: A Cross-Sectional Study in Iran During 2016-2017.
    Manshadi SAD; Alijani N; Salehi M; Dadras O; SeyedAlinaghi S; Ahangari A; Abdolahi A; Davoudi H; Alizade R
    Infect Disord Drug Targets; 2020; 20(5):748-751. PubMed ID: 31595854
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Laboratory characteristics of recent hepatitis A in Korea: ongoing epidemiological shift.
    Moon HW; Cho JH; Hur M; Yun YM; Choe WH; Kwon SY; Lee CH
    World J Gastroenterol; 2010 Mar; 16(9):1115-8. PubMed ID: 20205283
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of anti-HAV antibodies in multitransfused patients with beta-thalassemia.
    Siagris D; Kouraklis-Symeonidis A; Konstantinidou I; Christofidou M; Starakis I; Lekkou A; Papadimitriou C; Blikas A; Zoumbos N; Labropoulou-Karatza C
    World J Gastroenterol; 2008 Mar; 14(10):1559-63. PubMed ID: 18330948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis A virus seroprevalence in South Africa - Estimates using routine laboratory data, 2005-2015.
    Haeri Mazanderani A; Motaze NV; McCarthy K; Suchard M; du Plessis NM
    PLoS One; 2019; 14(6):e0216033. PubMed ID: 31242191
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seroepidemiology of hepatitis A among Greek children indicates that the virus is still prevalent: Implications for universal vaccination.
    Kyrka A; Tragiannidis A; Cassimos D; Pantelaki K; Tzoufi M; Mavrokosta M; Pedeli X; Athanassiadou F; Hatzimichael A; Konstantopoulos A; Kafetzis D; Papaevangelou V
    J Med Virol; 2009 Apr; 81(4):582-7. PubMed ID: 19235841
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India?
    Anand AC; Nagpal AK; Seth AK; Dhot PS
    J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiology of hepatitis A and hepatitis E infection and their determinants in adult Chinese community in Hong Kong.
    Wong KH; Liu YM; Ng PS; Young BW; Lee SS
    J Med Virol; 2004 Apr; 72(4):538-44. PubMed ID: 14981755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis A and B screening and vaccination rates among patients with chronic liver disease.
    Ramirez JC; Ackerman K; Strain SC; Ahmed ST; de Los Santos MJ; Sears D
    Hum Vaccin Immunother; 2016; 12(1):64-9. PubMed ID: 26836326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A study on seroprevalence of anti-HAV IgG in adults of 4 cities in China].
    Cheng YY; Nie JJ; Li J; Hou JL; Zhang XX; Ning Q; Gao XY; Ding HF; Liu XE; Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):896-9. PubMed ID: 20038329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparison of recent IgG anti-HAV prevalence between two hospitals in Seoul and Gyeonggi area].
    Kim TY; Sohn JH; Ahn SB; Son BK; Lee HL; Eun CS; Jeon YC; Han DS
    Korean J Hepatol; 2007 Sep; 13(3):363-9. PubMed ID: 17898552
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis A and hepatitis B infection prevalence and associated risk factors in men who have sex with men, Bangkok, 2006-2008.
    Linkins RW; Chonwattana W; Holtz TH; Wasinrapee P; Chaikummao S; Varangrat A; Tongtoyai J; Mock PA; Curlin ME; Sirivongrangson P; van Griensven F; McNicholl JM
    J Med Virol; 2013 Sep; 85(9):1499-505. PubMed ID: 23797893
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Seroprevalence of hepatitis A virus in patients with chronic liver disease from Kerala: impact on vaccination policy.
    John A; Chatni S; Narayanan VA; Balakrishnan V; Nair P
    J Indian Med Assoc; 2009 Dec; 107(12):859-61. PubMed ID: 20509469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Seroprevalence of hepatitis A virus infection in persons with HIV infection in Taiwan: implications for hepatitis A vaccination.
    Sun HY; Kung HC; Ho YC; Chien YF; Chen MY; Sheng WH; Hsieh SM; Wu CH; Liu WC; Hung CC; Chang SC
    Int J Infect Dis; 2009 Sep; 13(5):e199-205. PubMed ID: 19208490
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis A and B among young persons who inject drugs--vaccination, past, and present infection.
    Collier MG; Drobeniuc J; Cuevas-Mota J; Garfein RS; Kamili S; Teshale EH
    Vaccine; 2015 Jun; 33(24):2808-12. PubMed ID: 25889161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Aoufi S; Pascasio JM; Sousa JM; Sayago M; Ferrer MT; Gómez-Delgado E; De la Cruz MD; Alamo JM; Gómez-Bravo MA; Bernardos A; Márquez JL
    Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.